(9) proposed a diagnostic algorithm that includes CD56, arginase-1, and HMB45 (MART-1) immunostaining in the reported HART cases to prevent HART from being misdiagnosed as lipid-rich HCC. Here, MLANA is linked to hepatocellular carcinoma.